In the above commentary the clinical recommendations of the American College of Cardiology and the American Heart Association in their Expert Consensus Document 1 were quoted. These stated that co-administration of sildenafil with some CNS drugs-fluoxetine, fluvoxamine, carbemazepine, phenytoin and the statins-by a competitive inhibition of its metabolism may prolong the half-life of sildenafil (Viagra ® ). The manufacturers of Viagra, Pfizer Ltd, state that the Expert Consensus Document is incorrect on this and that these drugs do not affect the half-life of sildenafil. The only drugs which significantly interfere with the metabolism of sildenafil and prolong its half-life are those 3A4 inhibitors such as erythromycin, ketaconazole, cimetidine and the protease inhibitors. 
